World's Best Scientists 2026 revealed!
Award Badge
Microbiology
Australia
2026
Award Badge
Medicine
Australia
2023

D-Index & Metrics

Microbiology

D-Index
114
Citations
46769
World Ranking
205
National Ranking
4

Medicine

D-Index
115
Citations
49750
World Ranking
4533
National Ranking
126

Research.com Recognitions

  • 2026 - Research.com Microbiology in Australia Leader Award
  • 2025 - Research.com Microbiology in Australia Leader Award
  • 2023 - Research.com Medicine in Australia Leader Award
  • 2023 - Research.com Microbiology in Australia Leader Award
  • 2022 - Research.com Microbiology in Australia Leader Award
  • 2016 - Fellow of the Australian Academy of Health and Medical Science

Overview

Gregory J. Dore is affiliated with the University of New South Wales in Australia. Their research primarily focuses on medicine, with significant contributions in epidemiology, hepatology, infectious diseases, neurology, and public health, environmental and occupational health. The scientist has authored numerous publications addressing a range of topics, including hepatitis C virus research, hepatitis B virus studies, HIV, drug use and sexual risk, liver disease diagnosis and treatment, HIV/AIDS research and interventions, HIV/AIDS drug development and treatment, and the long-term effects of COVID-19.

Notable recent papers include:

  • Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection (2022, Nature Immunology)
  • Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study (2022, The Lancet. Gastroenterology & Hepatology)
  • AP-1 imprints a reversible transcriptional programme of senescent cells (2020, Nature Cell Biology)
  • A multinational Delphi consensus to end the COVID-19 public health threat (2022, Nature)
  • Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review (2023, The Lancet Global Health)

Frequent co-authors with whom Gregory J. Dore has collaborated include:

  • Jason Grebely
  • Gail Matthews
  • Behzad Hajarizadeh
  • Marianne Martinello
  • Heather Valerio

Their work has frequently appeared in a range of publication venues, such as:

  • International Journal of Drug Policy
  • Journal of Hepatology
  • Journal of Viral Hepatitis
  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Lancet. Gastroenterology & Hepatology

Gregory J. Dore's main fields of study and subfields span key areas in medicine and public health, contributing broadly to understanding and addressing viral hepatitis, infectious diseases, and related health concerns.

In recognition of their professional achievements, they were named a Fellow of the Australian Academy of Health and Medical Science in 2016.

Best Publications

  • IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

    Vijayaprakash Suppiah;Max Moldovan;Golo Ahlenstiel;Thomas Berg

  • Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

    Sarah Blach;Stefan Zeuzem;Michael Manns;Ibrahim Altraif

  • Epidemiology and natural history of HCV infection

    Behzad Hajarizadeh;Jason Grebely;Gregory J. Dore

  • Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies.

    J M Micallef;J M Kaldor;G J Dore

  • Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression†

    Hla-Hla Thein;Hla-Hla Thein;Qilong Yi;Gregory J. Dore;Murray D. Krahn;Murray D. Krahn

  • Estimating progression to cirrhosis in chronic hepatitis C virus infection.

    Anthony J. Freeman;Gregory J. Dore;Matthew G. Law;Max Thorpe

  • Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study.

    Unknown

  • Hepatitis C Virus Treatment for Prevention Among People Who Inject Drugs: Modeling Treatment Scale-Up in the Age of Direct-Acting Antivirals

    Natasha K. Martin;Peter Vickerman;Jason Grebely;Margaret Hellard

  • Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

    Graham S Cooke;Isabelle Andrieux-Meyer;Tanya L Applegate;Rifat Atun

  • Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression

    Reem Waziry;Behzad Hajarizadeh;Jason Grebely;Janaki Amin

  • Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis.

    Hla-Hla Thein;Qilong Yi;Gregory J Dore;Murray D Krahn

  • Changes to AIDS dementia complex in the era of highly active antiretroviral therapy

    Gregory J. Dore;Patricia K. Correll;Yueming Li;John M. Kaldor

  • Global burden of disease (GBD) for hepatitis C

    Y Hutin;ME Kitler;GJ Dore;JF Perz

  • The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection

    Jason Grebely;Kimberly A Page;Rachel Sacks-Davis;Martin Schim van der Loeff

  • Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

    Stefan Zeuzem;Graham R Foster;Stanley Wang;Armen Asatryan

  • Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States.

    Soumitri Barua;Robert Greenwald;Jason Grebely;Gregory J. Dore

  • Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial

    Ira M Jacobson;Gregory J Dore;Graham R Foster;Michael W Fried

  • Necroptosis microenvironment directs lineage commitment in liver cancer

    Marco Seehawer;Florian Heinzmann;Luana D’Artista;Jule Harbig

  • Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial

    Gregory J. Dore;Frederick Altice;Alain H. Litwin;Olav Dalgard

  • Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men

    Thijis van de Laar;Oliver Pybus;Sylvia Bruisten;David Brown

  • Treatment of Hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis

    Esther J Aspinall;Stephen Corson;Joseph S Doyle;Joseph S Doyle;Joseph S Doyle;Jason Grebely

  • Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1–6 without cirrhosis

    Paul Y. Kwo;Fred Poordad;Armen Asatryan;Stanley Wang

  • NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcome

    Stefan Zeuzem;Masashi Mizokami;Stephen Pianko;Alessandra Mangia

Frequent Co-Authors

Jason Grebely
Jason Grebely University of New South Wales
Gail V. Matthews
Gail V. Matthews University of New South Wales
Margaret Hellard
Margaret Hellard Burnet Institute
Andrew R. Lloyd
Andrew R. Lloyd University of New South Wales
Janaki Amin
Janaki Amin Macquarie University
John M. Kaldor
John M. Kaldor University of New South Wales
Matthew Law
Matthew Law University of New South Wales
Jacob George
Jacob George University of Sydney
Lisa Maher
Lisa Maher University of New South Wales
William D. Rawlinson
William D. Rawlinson University of New South Wales

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students pursuing Microbiology in the USA, exploring complementary online degrees can expand career opportunities. Many graduates dive into healthcare-related fields such as medical coding and health information management, which blend well with their scientific background.

One popular certification is becoming a certified professional coder. This role is essential for processing medical records accurately and efficiently, offering stable employment and competitive salaries.

Obtaining a bachelor’s degree in health information management further enhances job prospects. According to research, a health information management bachelor degree salary can be quite attractive, reflecting the demand for skilled professionals who manage patient data and comply with healthcare regulations.

To pursue this, students should consider enrolling in cahiim accredited health information management programs online. These accredited programs ensure quality education tailored to industry standards.

For those seeking quicker entry into the field, an accelerated medical billing and coding certificate online offers a streamlined path to gain essential skills and certifications without the commitment of a full degree.

Best Scientists Citing Gregory J. Dore

Trending Scientists